When MRCS encounters breast cancer metastases that have increased ECM stiffness, YAP/TAZ translocate into the nucleus to activate a mechano-sensitive promoter that drives the transcription of a downstream gene cytosine deaminase (CD). This evidence concerns the gene YAP1 and breast cancer.